Balyasny Asset Management LLC Illumina, Inc. Call Options Transaction History

Balyasny Asset Management LLC

9 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 14, 2023	SELL	$183.43 - $232.67 $26.2 Million - $33.3 Million	-143,000 Reduced 52.38%	130,000 $24.4 Million
Q1 2023 May 15, 2023	BUY	$193.75 - $232.55 $52.9 Million - $63.5 Million	273,000 New	273,000 $63.5 Million
Q3 2022 Nov 14, 2022	BUY	$177.23 - $227.44 $16.7 Million - $21.4 Million	94,000 New	94,000 $17.9 Million
Q2 2022 Aug 15, 2022	SELL	$181.58 - $368.0 $15.3 Million - $30.9 Million	-84,000 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$303.87 - $423.8 $24.9 Million - $34.8 Million	-82,000 Reduced 49.4%	84,000 $29.4 Million
Q4 2021 Feb 14, 2022	BUY	$347.28 - $421.83 $57.6 Million - $70 Million	166,000 New	166,000 $63.2 Million
Q3 2021 Nov 15, 2021	SELL	$405.61 - $524.84 $648,976 - $839,744	-1,600 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$372.84 - $481.5 $64.7 Million - $83.5 Million	-173,400 Reduced 99.09%	1,600 $757,000
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $35.4 Million - $40.3 Million	175,000	175,000 $38.2 Million

900

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.3B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Balyasny Asset Management LLC with notifications on news.